Aroxybutynin and Atomoxetine

Drug identity checked against registry records

Also recorded as AD109

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Continuation Protocol for Obstructive Sleep Apnea (OSA)NCT06566820ApnimedPhase 3Enrolling by invitation2026-06-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.